Aignostics releases AI tool for tumor microenvironment analysis
On October 15, 2025, Aignostics announced the public launch of Atlas H&E-TME, an AI application that analyzes tumor microenvironments using routine H&E slides—without special stains. Following early-access programs with pharma partners, the tool enables faster biomarker discovery and therapy assessment. Significance: A major step toward precision oncology powered by advanced computer-vision pathology.